Calliditas Therapeutics AB (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
19.45
0.99 (5.36%)
At close: May 20, 2022 4:00 PM
18.70
-0.75 (-3.86%)
After-hours:May 20, 2022 5:05 PM EDT
Income Statement (Trailing)
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
| Period Ended | 2021-12-31 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 229.35 | 0.4 | 0.4 | 0.87 | 47.06 | 47.06 | 185.3 | 184.83 | - | - | 0 |
| Revenue Growth (YoY) | 387.35% | -99.15% | -99.78% | -99.53% | - | - | - | - | - | - | - |
| Gross Profit | 229.35 | 0.4 | 0.4 | 0.87 | 47.06 | 47.06 | 185.3 | 184.83 | - | - | 0 |
| Selling, General & Admin | 390.23 | 248.07 | 182.49 | 141.72 | 101.63 | 70.89 | 71.09 | 62.88 | - | - | 31.13 |
| Research & Development | 357.49 | 303.98 | 277.34 | 241.37 | 209.09 | 190.39 | 173.19 | 149.83 | - | - | 99.26 |
| Other Operating Expenses | 6.09 | -0.63 | -1.26 | -2.5 | -1.84 | -4.65 | -1.36 | 0.14 | 0 | 0 | 2.09 |
| Operating Expenses | 753.8 | 551.41 | 458.58 | 380.59 | 308.88 | 256.63 | 242.92 | 212.85 | - | - | 132.48 |
| Operating Income | -524.46 | -551.01 | -458.18 | -379.72 | -261.82 | -209.57 | -57.62 | -28.02 | - | - | -132.48 |
| Interest Expense / Income | 9.25 | 62.14 | 51.02 | 56.98 | 24.96 | -10.6 | -3.07 | 5.41 | - | - | 0.01 |
| Other Expense / Income | -29.58 | -8.21 | -4.98 | -3.56 | -0.93 | -0.93 | -0.93 | -0.93 | 0 | 0 | -0.44 |
| Pretax Income | -504.13 | -604.94 | -504.22 | -433.13 | -285.85 | -198.05 | -53.62 | -32.5 | 0 | 0 | -132.05 |
| Income Tax | -3.84 | -11.19 | -8.98 | 0.36 | 0.26 | 0.18 | 0.12 | 0.08 | - | - | 0 |
| Net Income | -500.29 | -593.75 | -495.23 | -433.49 | -286.11 | -198.23 | -53.74 | -32.58 | - | - | -132.05 |
| Net Income Common | -500.29 | -593.75 | -495.23 | -433.49 | -286.11 | -198.23 | -53.74 | -32.58 | - | - | -132.05 |
| Shares Outstanding (Basic) | 50 | 50 | 50 | 46 | 46 | 46 | 46 | 46 | - | - | - |
| EPS (Basic) | -19.68 | -24.44 | -21.04 | -19.32 | -13.30 | -10.36 | -2.64 | -1.76 | - | - | -10.18 |
| EPS (Diluted) | -19.68 | -24.44 | -21.04 | -19.32 | -13.30 | -10.36 | -2.66 | -1.76 | - | - | -10.18 |
| Free Cash Flow Per Share | -18.75 | -19.64 | -17.00 | -13.36 | -10.14 | -2.08 | -1.75 | -3.07 | - | - | - |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - | - | - |
| Operating Margin | -228.67% | -137753.00% | -114543.75% | -43446.22% | -556.36% | -445.32% | -31.10% | -15.16% | - | - | - |
| Profit Margin | -218.14% | -148437.00% | -123808.50% | -49598.86% | -607.97% | -421.23% | -29.00% | -17.63% | - | - | - |
| Free Cash Flow Margin | -204.13% | -122619.75% | -106146.25% | -35375.40% | -498.64% | -102.50% | -21.87% | -38.48% | - | - | - |
| Effective Tax Rate | 0.76% | 1.85% | 1.78% | -0.08% | -0.09% | -0.09% | -0.21% | -0.24% | - | - | 0.00% |
| EBITDA | -494.88 | -542.8 | -453.2 | -376.16 | -260.9 | -208.64 | -56.7 | -27.09 | - | - | -132.04 |
| EBITDA Margin | -215.78% | -135700.25% | -113299.25% | -43038.44% | -554.39% | -443.36% | -30.60% | -14.66% | - | - | - |
| EBIT | -494.88 | -542.8 | -453.2 | -376.16 | -260.9 | -208.64 | -56.7 | -27.09 | - | - | -132.04 |
| EBIT Margin | -215.78% | -135700.25% | -113299.25% | -43038.44% | -554.39% | -443.36% | -30.60% | -14.66% | - | - | - |
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).